Piper Sandler Reiterates Overweight on Stereotaxis, Lowers Price Target to $3.5
Benzinga Newsdesk 5 months ago
NewsPrice TargetReiterationAnalyst Ratings
Piper Sandler analyst Adam Maeder reiterates Stereotaxis (AMEX:STXS) with a Overweight and lowers the price target from $4 to $3.5.
Piper Sandler analyst Adam Maeder reiterates Stereotaxis (AMEX:STXS) with a Overweight and lowers the price target from $4 to $3.5.